Clinical Trials
112 trialsA Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
Risk Communication Within Mexican-American Families
National Institutes of Health Clinical Center (CC)
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
CIEMAR
Cardiovascular and Interventional Radiological Society of Europe
DICHIMIO
University Hospital, Rouen
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
Compugen Ltd
Single-stapled Double Purse-string Technique for Colorectal Anastomosis
Vejle Hospital
COMPANION-003
Compass Therapeutics
CHALLENGE
Canadian Cancer Trials Group
EMOTION
Centre Antoine Lacassagne
DOCC
University Hospital, Rouen
ANGIOPREDICT. ICORG 12-16, V3
Cancer Trials Ireland
TraveraRTGx
Travera Inc
Comparison of the Left-Lateral Horizontal and Supine Positions for Colonoscopy Intervention: A Randomized Controlled Study
Celal Bayar University
DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer
Maltepe University
Clinical Study on the Expression of PHGDH and Its Prognostic Value in Colorectal Cancer Patients Receiving Immunotherapy
West China Hospital
Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative
H. Lee Moffitt Cancer Center and Research Institute
BENEFIT
Elsan
Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients
Mersin University
COLOCROSS
Centre Oscar Lambret
Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer
City of Hope Medical Center
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center
00-046
Memorial Sloan Kettering Cancer Center
EHCancer
Zagazig University
Piecemeal Resection and Advanced Histology Independently Predict Local Recurrence After Colorectal Snare-based Endoscopic Resection: a Time-to-event Cohort Study
University of Sao Paulo
FAMCAP
Hôpital Edouard Herriot
The Factors Influencing the Success of Redo Surgery and Anal Function for Anastomosis Failure or Local Tumor Recurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Intima Bioscience, Inc.
Pilot Study of Individualized Comprehensive Rehabilitation in Patients With Colorectal Cancer
Institute of Oncology Ljubljana
U-Screen
Milton S. Hershey Medical Center
Using Visual Arrays to Support Understanding of Genetic Risk
Massachusetts General Hospital
DELARC
Institut Cancerologie de l'Ouest
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
SWOG Cancer Research Network
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study
Roswell Park Cancer Institute
DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease
M.D. Anderson Cancer Center
Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands
Ballad Health
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute
Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt
Sohag University
Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
A New Classification System for Lymph Nodes in Colon Cancer: The Prognostic Significance of the Anatomical Distribution of Metastatic Lymph Nodes and the Number of Tumor Deposits
Sixth Affiliated Hospital, Sun Yat-sen University
PICoC
The Royal Wolverhampton Hospitals NHS Trust
T-REX
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
TAP
Trinity Health Michigan
Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
City of Hope Medical Center
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)
M.D. Anderson Cancer Center
Optimization of Adaptive Text Messages for Cancer Survivors (OATS II)
University of California, San Francisco
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
University of Washington
PeLear CCC
University of North Carolina, Chapel Hill
Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
MU-PRIOR
Erasmus Medical Center